Package 0069-0308-01

Brand: trazimera

Generic: trastuzumab-qyyp
NDC Package

Package Facts

Identity

Package NDC 0069-0308-01
Digits Only 0069030801
Product NDC 0069-0308
Description

1 VIAL in 1 CARTON (0069-0308-01) / 7.15 mL in 1 VIAL

Marketing

Marketing Status
Marketed Since 2021-03-10
Brand trazimera
Generic trastuzumab-qyyp
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "d159ec9c-8cae-4bd1-9526-09b2d8c665fc", "openfda": {"nui": ["N0000175661", "N0000020008"], "unii": ["P188ANX8CK"], "rxcui": ["2280732", "2280737", "2472791", "2472794"], "spl_set_id": ["b9c5e894-27d2-4245-a653-df986fed3c56"], "pharm_class_epc": ["HER2/neu Receptor Antagonist [EPC]"], "pharm_class_moa": ["HER2/Neu/cerbB2 Antagonists [MoA]"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (0069-0308-01)  / 7.15 mL in 1 VIAL", "package_ndc": "0069-0308-01", "marketing_start_date": "20210310"}], "brand_name": "Trazimera", "product_id": "0069-0308_d159ec9c-8cae-4bd1-9526-09b2d8c665fc", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["HER2/Neu/cerbB2 Antagonists [MoA]", "HER2/neu Receptor Antagonist [EPC]"], "product_ndc": "0069-0308", "generic_name": "trastuzumab-qyyp", "labeler_name": "Pfizer Laboratories Div Pfizer Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Trazimera", "active_ingredients": [{"name": "TRASTUZUMAB", "strength": "150 mg/7.15mL"}], "application_number": "BLA761081", "marketing_category": "BLA", "marketing_start_date": "20210310", "listing_expiration_date": "20261231"}